Viewing Study NCT06352008


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2025-12-29 @ 3:13 PM
Study NCT ID: NCT06352008
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2024-04-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: E20230553
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators